Investigation of salivary free amino acid profile for early diagnosis of breast cancer with ultra performance liquid chromatography-mass spectrometry.
Breast cancer (BC) is the second leading cause of cancer death in women worldwide. This study aimed at investigating salivary free amino acid (SFAA) profile to facilitate the early diagnosis of BC. Unstimulated whole saliva from BC patients (n=27) and randomly from healthy females (n=28) were assayed with ultra-performance liquid chromatography-mass spectrometry (UPLC-MS). Receiver operating characteristic curve (ROC) was used to evaluate the diagnostic performance of each of the amino acid (AA) biomarkers, or SFAA profile index for BC screening. Concentrations of 15 SFAAs demonstrated significant differences (P<0.05) between BC patients at stages I-II and healthy controls (HC). The area under the curve (AUC) values in HC vs BCs I-II based on single AA were from 0.695 to 0.866. The AUC for SFAA profile index combined Pro, Thr, His was 0.916 (sensitivity 88.2%, specificity 85.7%) in distinguishing HC from BCs I-II. The diagnostic potentials of 15 SFAAs as early diagnostic biomarkers for BC were verified and the diagnostic accuracy was improved in the use of SFAA profile index. The detection of SFAA profile is expected to be applied for the preclinical screening of early stage of BC in the future.